p53 and PD-1/PD-L1 expression contribute to disease progression and are correlated to immune infiltrates in urothelial carcinoma.

Although no significant correlation was observed between p53 expression and TIDE score, the p53 low expression group showed a trend towards high TIDE score, which has certain reference value for predicting BLCA immunotherapy (Fig. 9 C).

also in 53,322 other papers